Meanwhile, miR-130a inhibited lipid accumulation by down-regulating NAFLD-related genes PPARγ, SREBP1, SCD1, ACC1 and FASN. This evidence concerns the gene FASN and metabolic dysfunction-associated steatotic liver disease.